HBV-Integration Studies in the Clinic: Role in the Natural History of Infection

• Published in: Viruses Vol. 13; no. 3; p. 368
• Main Authors: Pollicino, Teresa, Caminiti, Giuseppe
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.02.2021; MDPI
• Subjects: Antigens; Antiviral agents; Biopsy; chronic hepatitis B; Chronic infection; Circular DNA; Cirrhosis; Deoxyribonucleic acid; DNA; Genomes; HBsAg; HBV DNA integration; HBx; Hepatitis B; hepatitis B virus infection; Hepatocellular carcinoma; Immune response; Infections; Integration; Life cycles; Liver cancer; Liver cirrhosis; Liver diseases; Lymphocytes T; Microenvironments; Oxidative stress; Proteins; Public health; Replication; Review; Ribonucleic acid; RNA; Tumorigenesis; Viral infections; chronic hepatitis B; HBV DNA integration; double-stranded DNA breaks; hepatitis B virus infection; HBsAg; oxidative stress; HBx
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v13030368

Hepatitis B virus (HBV) infection is a major global health problem causing acute and chronic liver disease that can lead to liver cirrhosis and hepatocellular carcinoma (HCC). HBV covalently closed circular DNA (cccDNA) is essential for viral replication and the establishment of a persistent infection. Integrated HBV DNA represents another stable form of viral DNA regularly observed in the livers of infected patients. HBV DNA integration into the host genome occurs early after HBV infection. It is a common occurrence during the HBV life cycle, and it has been detected in all the phases of chronic infection. HBV DNA integration has long been considered to be the main contributor to liver tumorigenesis. The recent development of highly sensitive detection methods and research models has led to the clarification of some molecular and pathogenic aspects of HBV integration. Though HBV integration does not lead to replication-competent transcripts, it can act as a stable source of viral RNA and proteins, which may contribute in determining HBV-specific T-cell exhaustion and favoring virus persistence. The relationship between HBV DNA integration and the immune response in the liver microenvironment might be closely related to the development and progression of HBV-related diseases. While many new antiviral agents aimed at cccDNA elimination or silencing have been developed, integrated HBV DNA remains a difficult therapeutic challenge.